Home
Company
About the Company
Management Team
Board of Directors
Company History
Careers
Philanthropy
Contact Us
Research and Development
Development Pipeline
Diseases and Products
Clinical Trials
Education
Information Request
Business Development
Business Development Strategy
Partners and Collaborators
Information Request
Investor Relations
Investor Home
Press Releases
Media Archive
Annual Reports
SEC Filings
Stock Quote - OSE
Stock Quote - Nasdaq
Historical Price Lookup
Investment Calculator
Analyst Coverage
Corporate Governance
Information Request
Diseases and Products
Click on the links below for more information about these products and their disease indications.
Core Candidates:
MN-221 (Exacerbations of Asthma/COPD)
Ibudilast (Neuropathic Pain, Drug Addiction, and Multiple Sclerosis)
Non-Core Candidates:
MN-001 (Bronchial Asthma)
MN-305 (Anxiety Disorders)
MN-001 (Interstitial Cystitis)
MN-221 (Preterm Labor)
MN-029 (Cancer)
MN-246 (Urinary Incontinence)